首页> 外文期刊>Autonomic neuroscience: basic & clinical >Alterations in sympathetic neuroeffector transmission to mesenteric arteries but not veins in DOCA-salt hypertension.
【24h】

Alterations in sympathetic neuroeffector transmission to mesenteric arteries but not veins in DOCA-salt hypertension.

机译:DOCA-盐高血压的交感神经效应传递到肠系膜动脉的变化,但没有变化。

获取原文
获取原文并翻译 | 示例
           

摘要

We studied hypertension-associated changes in prejunctional alpha(2) adrenergic receptor (alpha(2)-AR) function using amperometry to monitor in vitro norepinephrine (NE) measured as oxidation currents. Vasoconstriction was measured using video imaging. NE release was induced by electrical stimulation of sympathetic nerves associated with mesenteric arteries (MA) and veins (MV) of sham and DOCA-salt hypertensive rats. NE oxidation currents were larger in DOCA-salt compared to sham MA; there were no differences between currents in sham and DOCA-salt MV. Increases in NE oxidation currents followed a multi-exponential time course in sham MA. In DOCA-salt MA and sham and DOCA-salt MV, the time course was mono-exponential. Yohimbine (alpha(2)-AR antagonist, 1 microM), caused a mono-exponential increase in NE oxidation currents in sham and DOCA-salt MA. Yohimbine increased NE oxidation currents and constrictions more in sham compared to DOCA-salt MA and compared to MV. UK 14,304 (alpha(2)-AR agonist, 1.0 microM), reduced currents less in DOCA-salt MA and sham and DOCA-salt MV compared to sham MA. Prazosin (alpha(1)-AR antagonist, 0.1 microM) did not alter NE oxidation currents. Prazosin inhibited constrictions more in DOCA-salt compared to sham MA and almost completely blocked constrictions in sham and DOCA-salt MV. Prazosin-resistant constrictions in MA were blocked by the P2 receptor antagonist, PPADS (10 microM). Prejunctional alpha(2)-ARs modify NE concentrations near neuroeffector junctions in MA and MV. alpha(2)-AR function is most prominent in MA and is impaired in DOCA-salt MA but not MV. Purinergic transmission predominates in sham MA. NE is the dominant vasoconstrictor in DOCA-salt MA and sham and DOCA-salt MV.
机译:我们研究了与电流相关的高血压相关变化的连接前α(2)肾上腺素能受体(alpha(2)-AR)功能,使用安培法监测体外被测量为氧化电流的去甲肾上腺素(NE)。使用视频成像测量血管收缩。假性和假性DOCA盐高血压大鼠的与肠系膜动脉(MA)和静脉(MV)相关的交感神经的电刺激可诱导NE释放。与假MA相比,DOCA盐中的NE氧化电流更大。假电流和DOCA-盐MV之间没有差异。在深部MA中,NE氧化电流的增加遵循多个指数的时间过程。在DOCA-salt MA和sham和DOCA-salt MV中,时间过程是单指数的。育亨宾(alpha(2)-AR拮抗剂,1 microM),导致假和DOCA盐MA中NE氧化电流单指数增加。与DOCA-盐MA和MV相比,育亨宾增加了假手术中NE氧化电流和收缩的增加。 UK 14,304(alpha(2)-AR激动剂,1.0 microM),与sham MA相比,DOCA-salt MA和sham和DOCA-salt MV中的电流降低较少。吡唑嗪(α(1)-AR拮抗剂,0.1 microM)不会改变NE的氧化电流。与假MA相比,普拉唑嗪在DOCA-盐中抑制收缩的程度更大,并且在假和DOCA-盐MV中几乎完全阻断了收缩。 P2受体拮抗剂PPADS(10 microM)阻断了MA中对吡唑嗪耐药的收缩。结前α(2)-ARs修饰MA和MV中神经效应连接点附近的NE浓度。 alpha(2)-AR功能在MA中最为突出,而在DOCA-盐MA中却受损,但在MV中却没有。在深部MA中嘌呤能传播占主导。 NE是DOCA-盐MA和假和DOCA-盐MV中的主要血管收缩剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号